FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称IBALIZUMAB
异名/同义词IBALIZUMAB [INN]
IBALIZUMAB [MI]
IBALIZUMAB [USAN]
IBALIZUMAB [WHO-DD]
IBALIZUMAB, LICENSE HOLDER UNSPECIFIED
IBALIZUMAB-UIYK
IBALIZUMAB-UIYK [PURPLE BOOK CDER]
IBALIZUMAB-UIYK [WHO-DD]
IMMUNOGLOBULIN G4, ANTI-(HUMAN CD4 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL 5A8 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 5A8 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4, ANTI-(HUMAN CD4 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL 5A8 .GAMMA.4-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL 5A8 .KAPPA.-CHAIN, DIMER
IBALIZUMAB
TNX-355
TROGARZO
CAS登记号680188-33-4
物质唯一标识(Unique Ingredient Identifier)LT369U66CE
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System